News

BioPharma Dive43m
Merck to buy Verona and its lung drug in $10B deal
The New Jersey-based pharma has inked one of the biggest deals of the year in pursuit of a promising new way to treat COPD.
Fierce Pharma46m
Merck boosts respiratory portfolio with $10B acquisition of Verona and potential COPD blockbuster Ohtuvayre
Merck has pulled off another acquisition which fits in its “sweet spot,” as described by CEO Rob Davis, paying $10 billion ...
Merck dives into COPD treatments with $10 billion purchase of Verona Pharma
Merck & Co. Inc. is acquiring Verona Pharma PLC in a $10 billion deal that will expand the pharmaceutical giant’s portfolio ...
Merck acquires Raleigh pharma for $10 billion
The enormous deal comes as the Raleigh company's market cap has ballooned to several billion dollars. Destination Triangle: ...
Business Times2h
Merck to Acquire Verona Pharma for $10 Billion to Boost COPD Drug Portfolio
Merck & Co. said Wednesday it will acquire London-based Verona Pharma in a $10 billion all-cash deal, bolstering its respiratory treatment portfolio as the company moves to reduce long-term dependence ...
Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug
Merck is acquiring Verona Pharma for $10 billion, gaining COPD drug Ohtuvayre as part of its strategy to offset Keytruda's ...
Merck Is Buying Lung-Disease Biotech in $10 Billion Deal
Merck said Wednesday it would pay $10 billion to buy the biotech Verona Pharma, which sells a new lung-disease drug that ...
Merck spends $10 billion for Verona, gaining access to its COPD medication
Pharmaceutical giant Merck is buying Verona Pharma, a company that concentrates its efforts on respiratory diseases, in an ...